Search Results - "Graham, Galyna V."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2

    Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities by Graham, Galyna V., Conlon, J. Michael, Abdel-Wahab, Yasser H., Flatt, Peter R.

    Published in European journal of pharmacology (05-07-2020)
    “…This study has examined the in vitro and in vivo anti-diabetic properties of the peptidase-resistant analogues [D-Ser2]palmitoyl-paddlefish glucagon and…”
    Get full text
    Journal Article
  3. 3

    Glucagon-related peptides from phylogenetically ancient fish reveal new approaches to the development of dual GCGR and GLP1R agonists for type 2 diabetes therapy by Graham, Galyna V., Conlon, J. Michael, Abdel-Wahab, Yasser H., Flatt, Peter R.

    Published in Peptides (New York, N.Y. : 1980) (01-12-2018)
    “…•Glucagons and oxyntomodulins from phylogenetic ancient fish stimulate insulin release from clonal β-cells and mouse islets.•Insulinotropic activities of…”
    Get full text
    Journal Article
  4. 4

    Glucagon-like peptides-1 from phylogenetically ancient fish show potent anti-diabetic activities by acting as dual GLP1R and GCGR agonists by Graham, Galyna V., Conlon, J. Michael, Abdel-Wahab, Yasser H., Flatt, Peter R.

    Published in Molecular and cellular endocrinology (15-01-2019)
    “…Glucagon-like peptides-1 (GLP-1)from phylogenetically ancient fish (lamprey, dogfish, ratfish, paddlefish and bowfin) and from a teleost, the rainbow trout…”
    Get full text
    Journal Article
  5. 5

    A long-acting, dual-agonist analogue of lamprey GLP-1 shows potent insulinotropic, β-cell protective, and anorexic activities and improves glucose homeostasis in high fat-fed mice by Graham, Galyna V., McCloskey, Andrew, Abdel-Wahab, Yasser H., Conlon, J. Michael, Flatt, Peter R.

    Published in Molecular and cellular endocrinology (01-01-2020)
    “…Peptidase-resistant analogues of GLP-1 peptides from sea lamprey and paddlefish ([D-Ala2]palmitoyl-lamprey GLP-1 and [D-Ala2]palmitoyl-paddlefish GLP-1)…”
    Get full text
    Journal Article
  6. 6

    Evaluation of the insulinotropic and glucose-lowering actions of zebrafish GIP in mammalian systems: Evidence for involvement of the GLP-1 receptor by Graham, Galyna V., Conlon, J. Michael, Abdel-Wahab, Yasser H., Gault, Victor A., Flatt, Peter R.

    Published in Peptides (New York, N.Y. : 1980) (01-02-2018)
    “…•zfGIP stimulates insulin release from clonal β-cells and mouse islets.•zfGIP administration improves glucose tolerance in mice.•Insulin release from BRIN-BD11…”
    Get full text
    Journal Article
  7. 7

    Effects of long‐acting analogues of lamprey GLP‐1 and paddlefish glucagon on alpha‐ to beta‐cell transdifferentiation in an insulin‐deficient transgenic mouse model by Graham, Galyna V., Conlon, J. Michael, Moffett, R. Charlotte, Abdel‐Wahab, Yasser H., Flatt, Peter R.

    Published in Journal of peptide science (01-08-2021)
    “…The abilities of the long‐acting, dual‐agonist anti‐diabetic peptides [D‐Ala2]palmitoyl‐lamprey GLP‐1 and [D‐Ser2]palmitoyl‐paddlefish glucagon to induce…”
    Get full text
    Journal Article